Ling-yi Xiao

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Oncogenic PIK3CA mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma.

Oncogenic PIK3CA mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma.

Journal: Journal for immunotherapy of cancer

Published: June 15, 2026

The association between the GNB3 rs5443 C/C genotype and obesity phenotypes in Taiwanese individuals.

The association between the GNB3 rs5443 C/C genotype and obesity phenotypes in Taiwanese individuals.

Journal: BioMedicine

Published: May 08, 2025

Exploring the role of YES1 kinase in regulating cisplatin resistance through iTRAQ-based quantitative proteomic analysis in urothelial carcinoma.

Exploring the role of YES1 kinase in regulating cisplatin resistance through iTRAQ-based quantitative proteomic analysis in urothelial carcinoma.

Journal: American journal of cancer research

Published: January 12, 2025

Chitinase 3-like-1 Expression in the Microenvironment Is Associated with Neutrophil Infiltration in Bladder Cancer.

Chitinase 3-like-1 Expression in the Microenvironment Is Associated with Neutrophil Infiltration in Bladder Cancer.

Journal: International journal of molecular sciences

Published: September 25, 2023

Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process.

Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process.

Journal: Cells

Published: March 05, 2023

Silencing of FOXA2 decreases E-cadherin expression and is associated with lymph node metastasis in oral cancer.

Silencing of FOXA2 decreases E-cadherin expression and is associated with lymph node metastasis in oral cancer.

Journal: Oral diseases

Published: August 19, 2019

MAL-PDT inhibits oral precancerous cells and lesions via autophagic cell death.

MAL-PDT inhibits oral precancerous cells and lesions via autophagic cell death.

Journal: Oral diseases

Published: October 02, 2018

Poly ADP-ribose polymerase inhibition suppresses cisplatin toxicity in chronic myeloid leukemia cells.

Poly ADP-ribose polymerase inhibition suppresses cisplatin toxicity in chronic myeloid leukemia cells.

Journal: Anti-cancer drugs

Published: February 17, 2017

p53 modulates the effect of ribosomal protein S6 kinase1 (S6K1) on cisplatin toxicity in chronic myeloid leukemia cells.

p53 modulates the effect of ribosomal protein S6 kinase1 (S6K1) on cisplatin toxicity in chronic myeloid leukemia cells.

Journal: Pharmacological research

Published: October 31, 2016

Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells.

Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells.

Journal: European journal of pharmacology

Published: August 22, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026